| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
OBJECTIVE: To investigate the association of anticardiolipin antibody with the genesis of spontaneous abortion, fetal growth restriction (FGR), and preeclampsia. METHODS: Eight hundred sixty pregnant women constituted the study population. Anticardiolipin antibody was screened by enzyme-linked immunosorbent assay during the first trimester of pregnancy. The outcome of pregnancy in these women was analyzed prospectively, and the rate of occurrence of spontaneous abortion, preeclampsia, and FGR was compared in the anticardiolipin antibody-positive and -negative groups. RESULTS: Anticardiolipin antibody was positive in 60 of the 860 women (7.0%) and negative in 800 (93.0%). The rate of spontaneous abortions in the anticardiolipin antibody-positive group, 25.0%, was significantly higher than that in the anticardiolipin antibody-negative group, at 9.8% (P < .001; relative risk [RR] 2.56, 95% confidence interval (CI) 1.37-4.81). The rates of preeclampsia (11.7%) and FGR (11.7%) in the anticardiolipin antibody-positive group were also significantly higher than those in the -negative group (1.9 and 1.9%, respectively; for preeclampsia, P < .001; RR 6.22, 95% CI 2.43-16.0 and for FGR, P < .001; RR 6.22, 95% CI 2.43-16.0). CONCLUSIONS: Anticardiolipin antibody is associated with adverse outcomes of pregnancy such as spontaneous abortion, preeclampsia, and FGR.
This article has been cited by other articles:
|
|
 |
|
  S. M. Bates, I. A. Greer, I. Pabinger, S. Sofaer, and J. Hirsh Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 844S - 886S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I Krause, L Leibovici, M Blank, and Y Shoenfeld Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis Lupus, March 1, 2007; 16(3): 176 - 180. [Abstract] [PDF]
|
|
|
|
 |
|
 W. Lim, M. A. Crowther, and J. W. Eikelboom Management of Antiphospholipid Antibody Syndrome: A Systematic Review JAMA, March 1, 2006; 295(9): 1050 - 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Nielsen and O. B. Christiansen Prognostic impact of anticardiolipin antibodies in women with recurrent miscarriage negative for the lupus anticoagulant Hum. Reprod., June 1, 2005; 20(6): 1720 - 1728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Duckitt and D. Harrington Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies BMJ, March 12, 2005; 330(7491): 565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y Molad, T Borkowski, A Monselise, A Ben-Haroush, J Sulkes, M Hod, D Feldberg, and J Bar Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies Lupus, February 1, 2005; 14(2): 145 - 151. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Conde-Agudelo, J. Villar, and M. Lindheimer World Health Organization Systematic Review of Screening Tests for Preeclampsia Obstet. Gynecol., December 1, 2004; 104(6): 1367 - 1391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Lee, M. A. Brown, D. W. Branch, K. Ward, and R. M. Silver Anticardiolipin and Anti-{beta}2-Glycoprotein-I Antibodies in Preeclampsia Obstet. Gynecol., August 1, 2003; 102(2): 294 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Heilmann, G.-F. v. Tempelhoff, and K. Pollow Antiphospholipid Syndrome in Obstetrics Clinical and Applied Thrombosis/Hemostasis, April 1, 2003; 9(2): 143 - 150. [Abstract] [PDF]
|
|
|
|
|
|
G Roberts, M M Gordon, D Porter, A G Jardine, and I W Gibson Acute renal failure complicating HELLP syndrome, SLE and anti-phospholipid syndrome: successful outcome using plasma exchange therapy Lupus, April 1, 2003; 12(4): 251 - 257. [Abstract] [PDF]
|
|
|
|
|
|
J. Laasanen, M. Hiltunen, K. Punnonen, A. Mannermaa, and S. Heinonen Fibrinogen and Factor VII Promoter Polymorphisms in Women With Preeclampsia Obstet. Gynecol., August 1, 2002; 100(2): 317 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Empson, M. Lassere, J. C. Craig, and J. R. Scott Recurrent Pregnancy Loss With Antiphospholipid Antibody: A Systematic Review of Therapeutic Trials Obstet. Gynecol., January 1, 2002; 99(1): 135 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Buyon, D. Nugent, E. Mellins, and C. Sandborg Maternal Immunologic Diseases and Neonatal Disorders NeoReviews, January 1, 2002; 3(1): e3 - 10. [Full Text] [PDF]
|
|
|
|
|
|
Z. ALFIREVIC, H. A. MOUSA, V. MARTLEW, L. BRISCOE, M. PEREZ-CASAL, and C. H. TOH Postnatal Screening for Thrombophilia in Women With Severe Pregnancy Complications Obstet. Gynecol., May 1, 2001; 97(5): 753 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. DREYFUS, G. HEDELIN, R. KUTNAHORSKY, M. LEHMANN, B. VIVILLE, B. LANGER, A. FLEURY, M. M'BAREK, A. TREISSER, M.-L. WIESEL, et al. Antiphospholipid Antibodies and Preeclampsia: A Case-Control Study Obstet. Gynecol., January 1, 2001; 97(1): 29 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. HONDA, K. TAKAKUWA, I. HATAYA, M. YASUDA, T. KURABAYASHI, and K. TANAKA HLA-DQB1 and HLA-DPB1 Genotypes in Severe Preeclampsia Obstet. Gynecol., September 1, 2000; 96(3): 385 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Takakuwa, K. Honda, K. Ishii, I. Hataya, M. Yasuda, and K. Tanaka Studies on the HLA-DRB1 genotypes in Japanese women with severe pre-eclampsia positive and negative for anticardiolipin antibody using a polymerase chain reaction-restriction fragment length polymorphism method Hum. Reprod., December 1, 1999; 14(12): 2980 - 2986. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
